ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
Click "Analyze" to generate stock analysis
ADCT Price Trend and Signals
ADCT Option Volumes & Open Interests (aggregated)
ADCT Put Call Ratios and IV (aggregated)
ADCT Financials
2026-02-19Somewhat Bullishprice_signal
Monthly high detected.
2026-02-17Somewhat Bullishprice_signal
Monthly high detected.
2026-02-04Somewhat Bullishprice_signal
Monthly high detected.
2026-02-03Somewhat Bullishprice_signal
Monthly high detected.
2026-02-02Somewhat Bullishprice_signal
Monthly high detected.
2026-01-07Bullishmacd_signal
Golden cross below zero detected.
2025-12-19Bearishmacd_signal
Dead cross below zero detected.
2025-12-12Bullishmacd_signal
Golden cross below zero detected.
2025-12-10Somewhat Bullishbottom_signal_v1
Potential bottom confirmed based on multi-timeframe lows.
2025-12-08Somewhat Bearishprice_signal
Monthly low detected.
2025-12-05Somewhat Bearishprice_signal
Monthly low detected.
2025-12-04Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-12-04Somewhat Bearishprice_signal
Monthly low detected.
2025-12-03Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-12-03Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-12-03Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-12-03Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.
2025-12-03Somewhat Bearishprice_signal
Monthly low detected.
2025-12-02Somewhat Bullishprice_signal
Monthly high detected.
2025-11-24Somewhat Bullishmacd_signal
Golden cross above zero detected.
2025-11-20Neutraloption_volume_signal
Abnormal option volume detected compared to 5-day moving average.
2025-11-20Neutraloption_volume_signal
Abnormal option volume detected compared to 10-day moving average.
2025-11-20Neutraloption_volume_signal
Abnormal option volume detected compared to 20-day moving average.
2025-11-20Neutraloption_volume_signal
Abnormal option volume detected compared to 3 mon moving average.
2025-11-19Somewhat Bullishbottom_signal_v1
Potential bottom confirmed based on multi-timeframe lows.
2025-11-10Somewhat Bullishbottom_signal_v1
Potential bottom confirmed based on multi-timeframe lows.
2025-08-12Somewhat Bullishbottom_signal_v1
Potential bottom confirmed based on multi-timeframe lows.
2025-07-02Somewhat Bullishbottom_signal_v1
Potential bottom confirmed based on multi-timeframe lows.
2025-04-09Somewhat Bullishbottom_signal_v1
Potential bottom confirmed based on multi-timeframe lows.
2025-02-13Somewhat Bullishbottom_signal_v1
Potential bottom confirmed based on multi-timeframe lows.
2025-02-05Somewhat Bullishbottom_signal_v1
Potential bottom confirmed based on multi-timeframe lows.
2025-01-30Somewhat Bullishbottom_signal_v1
Potential bottom confirmed based on multi-timeframe lows.
2025-01-23Somewhat Bullishbottom_signal_v1
Potential bottom confirmed based on multi-timeframe lows.
2025-01-17Somewhat Bullishbottom_signal_v1
Potential bottom confirmed based on multi-timeframe lows.
2024-12-19Somewhat Bullishbottom_signal_v1
Potential bottom confirmed based on multi-timeframe lows.
2024-12-06Somewhat Bullishbottom_signal_v1
Potential bottom confirmed based on multi-timeframe lows.